BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35069183)

  • 1. The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction.
    Trompet S; Postmus I; Warren HR; Noordam R; Smit RAJ; Theusch E; Li X; Arsenault B; Chasman DI; Hitman GA; Munroe PB; Rotter JI; Psaty BM; Caulfield MJ; Krauss RM; Cupples AL; Jukema WJ
    Front Pharmacol; 2021; 12():679857. PubMed ID: 35069183
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.
    Dehghan A; Bis JC; White CC; Smith AV; Morrison AC; Cupples LA; Trompet S; Chasman DI; Lumley T; Völker U; Buckley BM; Ding J; Jensen MK; Folsom AR; Kritchevsky SB; Girman CJ; Ford I; Dörr M; Salomaa V; Uitterlinden AG; Eiriksdottir G; Vasan RS; Franceschini N; Carty CL; Virtamo J; Demissie S; Amouyel P; Arveiler D; Heckbert SR; Ferrières J; Ducimetière P; Smith NL; Wang YA; Siscovick DS; Rice KM; Wiklund PG; Taylor KD; Evans A; Kee F; Rotter JI; Karvanen J; Kuulasmaa K; Heiss G; Kraft P; Launer LJ; Hofman A; Markus MR; Rose LM; Silander K; Wagner P; Benjamin EJ; Lohman K; Stott DJ; Rivadeneira F; Harris TB; Levy D; Liu Y; Rimm EB; Jukema JW; Völzke H; Ridker PM; Blankenberg S; Franco OH; Gudnason V; Psaty BM; Boerwinkle E; O'Donnell CJ
    PLoS One; 2016; 11(3):e0144997. PubMed ID: 26950853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study.
    Postmus I; Johnson PC; Trompet S; de Craen AJ; Slagboom PE; Devlin JJ; Shiffman D; Sacks FM; Kearney PM; Stott DJ; Buckley BM; Sattar N; Ford I; Westendorp RG; Jukema JW
    Atherosclerosis; 2014 Jul; 235(1):58-64. PubMed ID: 24816038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses.
    Trompet S; de Craen AJ; Postmus I; Ford I; Sattar N; Caslake M; Stott DJ; Buckley BM; Sacks F; Devlin JJ; Slagboom PE; Westendorp RG; Jukema JW;
    BMC Med Genet; 2011 Oct; 12():131. PubMed ID: 21977987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
    Postmus I; Trompet S; Deshmukh HA; Barnes MR; Li X; Warren HR; Chasman DI; Zhou K; Arsenault BJ; Donnelly LA; Wiggins KL; Avery CL; Griffin P; Feng Q; Taylor KD; Li G; Evans DS; Smith AV; de Keyser CE; Johnson AD; de Craen AJ; Stott DJ; Buckley BM; Ford I; Westendorp RG; Slagboom PE; Sattar N; Munroe PB; Sever P; Poulter N; Stanton A; Shields DC; O'Brien E; Shaw-Hawkins S; Chen YD; Nickerson DA; Smith JD; Dubé MP; Boekholdt SM; Hovingh GK; Kastelein JJ; McKeigue PM; Betteridge J; Neil A; Durrington PN; Doney A; Carr F; Morris A; McCarthy MI; Groop L; Ahlqvist E; ; Bis JC; Rice K; Smith NL; Lumley T; Whitsel EA; Stürmer T; Boerwinkle E; Ngwa JS; O'Donnell CJ; Vasan RS; Wei WQ; Wilke RA; Liu CT; Sun F; Guo X; Heckbert SR; Post W; Sotoodehnia N; Arnold AM; Stafford JM; Ding J; Herrington DM; Kritchevsky SB; Eiriksdottir G; Launer LJ; Harris TB; Chu AY; Giulianini F; MacFadyen JG; Barratt BJ; Nyberg F; Stricker BH; Uitterlinden AG; Hofman A; Rivadeneira F; Emilsson V; Franco OH; Ridker PM; Gudnason V; Liu Y; Denny JC; Ballantyne CM; Rotter JI; Adrienne Cupples L; Psaty BM; Palmer CN; Tardif JC; Colhoun HM; Hitman G; Krauss RM; Wouter Jukema J; Caulfield MJ
    Nat Commun; 2014 Oct; 5():5068. PubMed ID: 25350695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke.
    Hindorff LA; Lemaitre RN; Smith NL; Bis JC; Marciante KD; Rice KM; Lumley T; Enquobahrie DA; Li G; Heckbert SR; Psaty BM
    Pharmacogenet Genomics; 2008 Aug; 18(8):677-82. PubMed ID: 18622260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
    Peters BJ; Pett H; Klungel OH; Stricker BH; Psaty BM; Glazer NL; Wiggins KL; Bis JC; de Boer A; Maitland-van der Zee AH
    Atherosclerosis; 2011 Aug; 217(2):458-64. PubMed ID: 21741043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
    Jafri H; Alsheikh-Ali AA; Karas RH
    Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of pharmacogenetic variation on the effects of statins.
    Maggo SD; Kennedy MA; Clark DW
    Drug Saf; 2011 Jan; 34(1):1-19. PubMed ID: 21142270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction.
    Larsson SC; Burgess S; Michaëlsson K
    JAMA; 2017 Jul; 318(4):371-380. PubMed ID: 28742912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients.
    Mills EJ; O'Regan C; Eyawo O; Wu P; Mills F; Berwanger O; Briel M
    Eur Heart J; 2011 Jun; 32(11):1409-15. PubMed ID: 21385791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
    J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
    Yip VL; Pirmohamed M
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls.
    Preuss M; König IR; Thompson JR; Erdmann J; Absher D; Assimes TL; Blankenberg S; Boerwinkle E; Chen L; Cupples LA; Hall AS; Halperin E; Hengstenberg C; Holm H; Laaksonen R; Li M; März W; McPherson R; Musunuru K; Nelson CP; Burnett MS; Epstein SE; O'Donnell CJ; Quertermous T; Rader DJ; Roberts R; Schillert A; Stefansson K; Stewart AF; Thorleifsson G; Voight BF; Wells GA; Ziegler A; Kathiresan S; Reilly MP; Samani NJ; Schunkert H;
    Circ Cardiovasc Genet; 2010 Oct; 3(5):475-83. PubMed ID: 20923989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.